TRACON Pharmaceuticals (TCON) Competitors $0.03 0.00 (-1.67%) (As of 11:31 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends TCON vs. TCBP, NEXI, SMFL, SEEL, HSTO, NAVB, CALA, VAXX, SCPS, and AMPEShould you be buying TRACON Pharmaceuticals stock or one of its competitors? The main competitors of TRACON Pharmaceuticals include TC Biopharm (TCBP), NexImmune (NEXI), Smart for Life (SMFL), Seelos Therapeutics (SEEL), Histogen (HSTO), Navidea Biopharmaceuticals (NAVB), Calithera Biosciences (CALA), Vaxxinity (VAXX), Scopus BioPharma (SCPS), and Ampio Pharmaceuticals (AMPE). These companies are all part of the "pharmaceutical products" industry. TRACON Pharmaceuticals vs. TC Biopharm NexImmune Smart for Life Seelos Therapeutics Histogen Navidea Biopharmaceuticals Calithera Biosciences Vaxxinity Scopus BioPharma Ampio Pharmaceuticals TC Biopharm (NASDAQ:TCBP) and TRACON Pharmaceuticals (NASDAQ:TCON) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, community ranking, risk, analyst recommendations, earnings and institutional ownership. Do insiders & institutionals have more ownership in TCBP or TCON? 16.3% of TC Biopharm shares are owned by institutional investors. Comparatively, 11.6% of TRACON Pharmaceuticals shares are owned by institutional investors. 15.4% of TC Biopharm shares are owned by insiders. Comparatively, 5.3% of TRACON Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has higher earnings and valuation, TCBP or TCON? TRACON Pharmaceuticals has higher revenue and earnings than TC Biopharm. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTC Biopharm$4.76M0.07-$7.35MN/AN/ATRACON Pharmaceuticals$12.05M0.01-$3.59M$3.730.01 Do analysts rate TCBP or TCON? TRACON Pharmaceuticals has a consensus target price of $60.00, suggesting a potential upside of 203,289.83%. Given TRACON Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe TRACON Pharmaceuticals is more favorable than TC Biopharm.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TC Biopharm 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00TRACON Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk & volatility, TCBP or TCON? TC Biopharm has a beta of 0.24, indicating that its stock price is 76% less volatile than the S&P 500. Comparatively, TRACON Pharmaceuticals has a beta of 1.43, indicating that its stock price is 43% more volatile than the S&P 500. Does the media refer more to TCBP or TCON? In the previous week, TC Biopharm's average media sentiment score of 0.00 equaled TRACON Pharmaceuticals'average media sentiment score. Company Overall Sentiment TC Biopharm Neutral TRACON Pharmaceuticals Neutral Is TCBP or TCON more profitable? TC Biopharm's return on equity of 0.00% beat TRACON Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets TC BiopharmN/A N/A N/A TRACON Pharmaceuticals N/A -237.65%57.29% Does the MarketBeat Community prefer TCBP or TCON? TRACON Pharmaceuticals received 266 more outperform votes than TC Biopharm when rated by MarketBeat users. Likewise, 56.57% of users gave TRACON Pharmaceuticals an outperform vote while only 50.00% of users gave TC Biopharm an outperform vote. CompanyUnderperformOutperformTC BiopharmOutperform Votes150.00% Underperform Votes150.00% TRACON PharmaceuticalsOutperform Votes26756.57% Underperform Votes20543.43% SummaryTRACON Pharmaceuticals beats TC Biopharm on 8 of the 12 factors compared between the two stocks. Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Get TRACON Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TCON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TCON vs. The Competition Export to ExcelMetricTRACON PharmaceuticalsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$101,000.00$2.95B$5.08B$8.80BDividend YieldN/A1.91%5.02%4.07%P/E Ratio0.0117.5291.2813.60Price / Sales0.01280.411,226.2187.40Price / Cash0.02169.3839.4536.27Price / Book-0.084.366.906.33Net Income-$3.59M-$41.63M$118.83M$225.93M7 Day PerformanceN/A-5.54%-1.92%-0.96%1 Month PerformanceN/A-7.28%-3.75%1.06%1 Year PerformanceN/A25.27%31.37%26.59% TRACON Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TCONTRACON Pharmaceuticals1.1902 of 5 stars$0.03-1.7%$60.00+203,289.8%-99.1%$101,000.00$12.05M0.0120Analyst ForecastGap UpTCBPTC Biopharm0.1431 of 5 stars$0.63flatN/A-99.4%$334,000.00$4.76M0.0041Gap DownNEXINexImmuneN/A$0.22-8.3%N/A-90.3%$306,000.00N/A0.006News CoverageGap DownSMFLSmart for LifeN/A$0.02-56.5%N/A-99.6%$142,000.00$8.23M0.00110Gap DownSEELSeelos TherapeuticsN/A$0.38+8.6%N/A-99.9%$141,000.00$2.20M0.0020Gap UpHSTOHistogenN/A$0.03flatN/A-92.6%$115,000.00$19,000.00-0.017Gap UpNAVBNavidea BiopharmaceuticalsN/A$0.00flatN/A-98.3%$100,000.00$70,000.000.0010CALACalithera BiosciencesN/A$0.01flatN/A-76.0%$35,000.00$9.75M0.0060VAXXVaxxinityN/A$0.00flatN/A-100.0%$25,000.00$70,000.000.0090SCPSScopus BioPharmaN/A$0.00flatN/A-99.3%$13,000.00N/A0.009AMPEAmpio PharmaceuticalsN/A$0.01+∞N/A-99.6%$11,000.00N/A0.0020Gap Down Related Companies and Tools Related Companies TC Biopharm Competitors NexImmune Competitors Smart for Life Competitors Seelos Therapeutics Competitors Histogen Competitors Navidea Biopharmaceuticals Competitors Calithera Biosciences Competitors Vaxxinity Competitors Scopus BioPharma Competitors Ampio Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TCON) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRACON Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TRACON Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TCON Stock Alerts